Resmed Inc (RMD) Directors and Executive Officers - CSIMarket
CSIMarket
 
Resmed Inc   (NYSE: RMD)

Resmed Inc

Officers & Directors


Michael J. Farrell
Chief Executive Officer and Chairman

Brett A. Sandercock
Chief Financial Officer

De Witte
Director

Carol J. Burt
Director

John Hernandez
Director

Peter C. Farrell
Director and Chair Emeritus

Richard Sulpizio
Director

Ron Taylor
Director

Karen Drexler
Director

Desney Tan
Director

Harjit Gill
Director


Auditor for the Company since San Diego, California ,

Resmed Inc currently has 11370 employees.

  News about Resmed Inc Key Personnel

ResMeds Forward-Thinking 2030 Strategy: A Robust Blueprint for Sustainable Growth and Shareholder Value

In a significant move aimed at securing its position as a leader in the healthcare sector, ResMed (NYSE: RMD, ASX: RMD) unveiled its ambitious 2030 Strategy during an Investor Day event held in New York City on September 30, 2024. This new initiative is designed to drive growth, enhance profitability, and maximize shareholder returns, reflecting ResMed s commitment to innovation and operational excellence.The backbone of ResMed’s 2030 Strategy lies in its comprehensive approach to product and technology innovation, which will serve as a catalyst for accelerated growth. The company has set an ambitious target to help more than 500 million people around the globe achieve their full health potential by the ye...






RMD Management Effectiveness RMD Revenue per Employee RMD Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.